Marion McCourt - 04 Nov 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Commercial
Signature
/s/** Marion McCourt
Issuer symbol
REGN
Transactions as of
04 Nov 2022
Net transactions value
-$355,360
Form type
4
Filing time
07 Nov 2022, 15:05:05 UTC
Previous filing
02 Nov 2022
Next filing
02 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $372,460 +1,000 +5.1% $372.46 20,644 04 Nov 2022 Direct
transaction REGN Common Stock Sale $727,820 -1,000 -4.8% $727.82 19,644 04 Nov 2022 Direct
holding REGN Common Stock 138 04 Nov 2022 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,000 -8.4% $0.000000 10,950 04 Nov 2022 Common Stock 1,000 $372.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award vests in four equal annual installments, commencing one year after the date of grant.